A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Vitamin P4 Liposome | Vitamin P4, also known as Troxerutin, inhibits platelet aggregation, prevents thrombus formation, improves blood circulation, increases capillary resistance, treats acute ischemic brain injury, and helps improve certain vascular disorders in the body. This product is a pre-formulated liposome encapsulating Vitamin P4. It is only for research purposes. Group: Drug-loaded liposome. |  |
| Vitexdoin A | Vitexdoin A isolated from the herbs of Vitex negundo. Synonyms: (3R,4S)-6,7-Dihydroxy-4-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-3,4-dihydro-2-naphthalenecarbaldehyde. Grade: >95%. CAS No. 1186021-77-1. Molecular formula: C19H18O6. Mole weight: 342.4. |  |
| Vitexilactone | Vitexilactone isolated from the seeds of Vitex trifolia L. Uses: Antifungal; antibacterial. Synonyms: 4-[2-[(1R,4aα)-Decahydro-4β-acetoxy-1α-hydroxy-2α,5,5,8aβ-tetramethylnaphthalen-1-yl]ethyl]furan-2(5H)-one; 4-[2-[(4aα)-4β-Acetoxy-1-hydroxy-2α,5,5,8aβ-tetramethyldecalin-1β-yl]ethyl]-2(5H)-furanone; [(1R,3R,4R,4aS,8aS)-4-hydroxy-3,4a,8,8-tetramethyl-4-[2-. Grade: 0.97. CAS No. 61263-49-8. Molecular formula: C22H34O5. Mole weight: 378.5. | |
| Vitexilactone | Vitexilactone is a diterpenoid that can be isolated from the leaves of Vitex negundo L. Vitexilactone shows antimicrobial activity towards E. coli. Vitexilactone induces cell apoptosis and inhibits cell cycle of cancer cells. Vitexilactone can be used for the research of cancer[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 61263-49-8. Pack Sizes: 1 mg; 5 mg. Product ID: HY-N1079. |  |
| Vitexin | Vitexin is a c-glycosylated flavone, and is found in various medicinal plants species such as Trigonella foenum-graecum Linn. Vitexin has a wide range of pharmacological effects, including anti-oxidant, anti-cancer, anti-inflammatory, anti-hyperalgesic, and neuroprotective effects[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 3681-93-4. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-N0013. | |
| Vitexin | Vitexin. Group: Biochemicals. Alternative Names: 8-Glucopyranosyl apigenin; 8-Glucosylapigenin; Orientoside. Grades: Plant Grade. CAS No. 3681-93-4. Pack Sizes: 20mg. Molecular Formula: C21H20O10, Molecular Weight: 432.377999999999. US Biological Life Sciences. |  Worldwide |
| Vitexin | Vitexin is a class of nature lignan compounds isolated from the seeds of Vitex trifolia L. What different from the classic lignans is its action and anticancer effect is mediated by the mechanisms, vitexin-induced antitumor effect and cytotoxic activity is exerted through proapoptotic process, which is mediated by a decreased Bcl-2/Bax ratio and activation of caspases. Vitexin inhibits the activities of anti-nociceptive, anti-spasmodic and anti-oxidant. Uses: Anti-nociceptive; anti-spasmodic; anti-oxidant. Synonyms: 8-D-Glucosyl-4,5,7-trihydroxy-flavone; 8-C-b-D-Glucopyranosylapigenin; Oritentoside. Grade: >98%. CAS No. 3681-93-4. Molecular formula: C21H20O10. Mole weight: 432.38. | |
| Vitexin 2''-O-p-coumarate | Vitexin 2''-O-p-coumarate. Group: Biochemicals. Grades: Plant Grade. CAS No. 59282-55-2. Pack Sizes: 5mg. Molecular Formula: C30H26O12, Molecular Weight: 578.53. US Biological Life Sciences. | Worldwide |
| Vitexin 2''-O-rhamnoside | Vitexin 2''-O-rhamnoside. Group: Biochemicals. CAS No. 64820-99-1. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Vitexin 2''-O-rhamnoside | Vitexin-2''-O-rhamnoside, which is found in the leaves of Crataegus pinnatifida Bunge, could contribute to the protection against H2O2-mediated oxidative stress damage and could be safely used for a wide range of concentrations. Synonyms: 2-O-Rhamnosylvitexin; 8-[2-O-(6-Deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 2''-O-Rhamnosylvitexin; 2''-O-α-L-Rhamnopyranosylvitexin; 2''-Rhamnosylvitexin; Apigenin 8-C-neohesperidoside; Apigenin 8-C-α-L-rhamnopyranosyl-(1→2)-β-D-glucopyranoside]; Vitexin 2''-O-α-L-rhamnopyranoside; Vitexin 2''-rhamnoside; Vitexin 2''-α-L-rhamnopyranoside; Vitexin-2''-O-rhamnoside; Vitexin-2'-O-rhamnoside. Grade: >98%. CAS No. 64820-99-1. Molecular formula: C27H30O14. Mole weight: 578.52. | |
| vitexin 2''-O-rhamnoside 7-O-methyltransferase | The flavonoids vitexin and isovitexin 2''-O-arabinoside do not act as substrates for the enzyme from oats (Avena sativa). Group: Enzymes. Enzyme Commission Number: EC 2.1.1.153. CAS No. 90698-29-6. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-1749; vitexin 2''-O-rhamnoside 7-O-methyltransferase; EC 2.1.1.153; 90698-29-6. Cat No: EXWM-1749. |  |
| Vitexin 4''-O-glucoside | Vitexin 4''-O-glucoside. Group: Biochemicals. CAS No. 178468-00-3. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Vitexin-4''-O-glucoside | Vitexin-4''-O-glucoside (4''-O-Glucosylvitexin) is an orally active natural flavonoid component with multiple pharmacological effects including antioxidation, anti-inflammation, cytoprotection and anti-apoptosis. Vitexin-4''-O-glucoside regulates the MAPK signaling pathway by downregulating the phosphorylation levels of JNK and p38, thereby blocking endoplasmic reticulum stress responses. Vitexin-4''-O-glucoside alleviates oxidative stress by reducing MDA content and upregulating the activities of SOD and CAT, attenuates inflammation by downregulating the expressions of inflammatory factors TNF-α, IL-1β and IL-6, and also reduces LDH release and inhibits caspase-3 activation. Vitexin-4''-O-glucoside effectively improves drug-induced acute liver injury and exerts significant protective effects against myocardial hypoxia/reoxygenation injury. Vitexin-4''-O-glucoside can be used in studies on acute liver injury, cardiovascular diseases and myocardial hypoxia-reoxygenation injury[1][2][3][4]. Uses: Scientific research. Category: Natural products. Alternative Names: 4''-O-Glucosylvitexin. CAS No. 178468-00-3. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg. Product ID: HY-N5073. | |
| Vitexin Argininate | Vitexin Argininate. Group: Biochemicals. Grades: Plant Grade. CAS No. Pack Sizes: 20mg. US Biological Life Sciences. | Worldwide |
| vitexin β-glucosyltransferase | Vitexin is a flavonoid from Cannabis sativa (hemp) and some populations of Silene alba. Group: Enzymes. Synonyms: uridine diphosphoglucose-vitexin 2''-glucosyltransferase. Enzyme Commission Number: EC 2.4.1.105. CAS No. 76828-68-7. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2333; vitexin β-glucosyltransferase; EC 2.4.1.105; 76828-68-7; uridine diphosphoglucose-vitexin 2''-glucosyltransferase. Cat No: EXWM-2333. | |
| Vitexolide D | Vitexolide D is extracted from the herbs of Vitex vestita. It displays moderate antibacterial activity against a panel of 46 Gram-positive strains. It has cytotoxic activities against the human fetal lung fibroblast MRC5 cell line and HCT-116 cancer cell line. Synonyms: 12-Hydroxy-8(17),13-labdadien-16,15-olide; 4-[(1S)-2-[(1S,4aS,8aS)-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-1-hydroxyethyl]-2H-furan-5-one. Grade: 98.5%. CAS No. 1788090-69-6. Molecular formula: C20H30O3. Mole weight: 318.45. | |
| Viton Powder | Viton Powder. CAS No. 19011-17-0. Mole weight: 233.04 g/mol. Purity: 99.9%. |  |
| Vitronectin (367-378) | Vitronectin (367-378) is a peptide corresponding to residues 367-378 of Vitronectin. Vitronectin is a multifunctional glycoprotein known in several human tumors for its adhesive role in processes such as cell growth, angiogenesis and metastasis[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1217344-74-5. Pack Sizes: 5 mg; 10 mg. Product ID: HY-P2452. | |
| Vixarelimab | Vixarelimab (KPL-716) is a human anti-oncostatin M (OSM) receptor β subunit monoclonal antibody. Vixarelimab inhibits IL-31 and OSM signalling. Vixarelimab can be used in studies of inflammatory skin diseases such as atopic dermatitis and itchy nodular rash[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: KPL-716. CAS No. 2243320-83-2. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg. Product ID: HY-P99519. | |
| Vixticibart | Vixticibart (REGN-5381) is a fully human IgG4 monoclonal antibody and NPR1 agonist that targets NPR1. Vixticibart stabilizes the receptor in an activated conformation by binding to the N-terminal domain of NPR1, and enhances the activity of endogenous ligands ANP and BNP without blocking ligand binding when these ligands are present. Vixticibart exerts vasodilatory and hypotensive effects by inducing cGMP production, preferentially dilating venous vessels to reduce systolic and venous pressure, but does not induce diuresis and may trigger a compensatory increase in heart rate. Vixticibart produces a synergistic hypotensive effect when combined with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and is currently mainly used in research related to heart failure and hypertension[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: REGN-5381. CAS No. 2845128-05-2. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg. Product ID: HY-P990951. | |
| Vixtimotamab | Vixtimotamab (AMV-564; TandAb T564) is a bispecific tetravalent tandem diabody (TandAb) that targets human CD33 and human CD3 antigens. Vixtimotamab can be used for the research of acute myeloid leukemia (AML)[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: AMV-564; TandAb T564. CAS No. 2243775-32-6. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99958. | |
| Vizenpistat | Vizenpistat (SR-8541A) is an orally active ENPP1 inhibitor. Vizenpistat increases cGAMP levels, blocks 23-cGAMP hydrolysis, inhibits adenosine production, regulates innate immune signaling mediated by the STING pathway, and modulates anti-tumor immune responses. Vizenpistat is applicable to research related to breast cancer and metastatic microsatellite-stable colorectal cancer[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: SR-8541A. CAS No. 2687222-58-6. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-176296. | |
| VJDT | VJDT is a TREM1 inhibitor that can effectively block TREM1 signaling. VJDT inhibits tumor cell proliferation and migration and induces cell cycle arrest. VJDT has immunomodulatory and antitumor activities, and can be used for the research of tumors such as melanoma[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2765319-65-9. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-157122. | |
| VK-0214 | VK-0214 is an agonist of the thyroid β receptor (TRβ). By activating the expression of ABCD2, it can reduce the accumulation of very long-chain fatty acids (VLCFAs) and further alleviate glioblastoma multiforme. VK-0214 has the effect of regulating fatty acid metabolism and can be used in the research of X-linked adrenoleukodystrophy (X-ALD)[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 852949-30-5. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-156679. | |
| VK-2019 | VK-2019 is an orally bioavailable selective inhibitor of EBNA1. By binding to the protein-DNA interface to interfere with the recruitment and anchoring of the viral DNA replication machinery, VK-2019 effectively blocks the replication and proliferation of EBV in latently infected cells. VK-2019 reduces the copy number and gene expression level of Epstein-Barr virus in tumor cells, decreases the number of EBER-positive cells, and exhibits significant antiviral, immunomodulatory and antiproliferative activities. VK-2019 successfully inhibits tumor growth in EBV-dependent xenograft models. VK-2019 has favorable systemic exposure and acceptable safety profiles, and is widely used in research on advanced nasopharyngeal carcinoma and various EBV-associated cancers[1][2][3]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2044520-06-9. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg. Product ID: HY-W725179. | |
| VKGILS-NH2 | VKGILS-NH2. Group: Biochemicals. Grades: Purified. CAS No. 942413-05-0. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| VKGILS-NH2 | VKGILS-NH2 is a reversed control peptide for SLIGKV-NH2, which is a protease-activated receptor 2 (PAR2) agonist. Synonyms: retro-PAR-2 (1-6) amide (human); retro-SLIGKVamide; Thrombin Receptor-Like 1 (6-1) amide (human); Proteinase Activated Receptor 2 (6-1) amide (human); PAR-2 (6-1) amide (human). Grade: 98%. CAS No. 942413-05-0. Molecular formula: C28H54N8O7. Mole weight: 614.79. | |
| VKGILS-NH2 acetate | VKGILS-NH2 acetate is a reversed control peptide for SLIGKV-NH2, which is a protease-activated receptor 2 (PAR2) agonist. Synonyms: H-Val-Lys-Gly-Ile-Leu-Ser-NH2.CH3CO2H; L-valyl-L-lysyl-glycyl-L-isoleucyl-L-leucyl-L-serinamide acetic acid. Grade: ≥95%. CAS No. 2763585-10-8. Molecular formula: C28H54N8O7.C2H4O2. Mole weight: 674.83. | |
| VK-II-36 | VK-II-36 is a carvedilol analog that suppresses sarcoplasmic reticulum Ca2+release but does not block the β-receptor.VK-II-36 inhibits triggered activities evoked by both early and delayed after depolarizations[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 955371-66-1. Pack Sizes: 5 mg; 10 mg. Product ID: HY-111014. | |
| VL285 | VL285 is a potent VHL ligand with an IC50 of 0.34 μM[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1448188-57-5. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-111663. | |
| VLS-1272 | VLS-1272 (Compound 22) is an orally active KIF18A inhibitor that binds to the KIF18A-microtubule complex in an ATP-noncompetitive manner (IC50 = 41 nM), blocking its ATPase activity and inhibiting microtubule translocation. This leads to abnormal accumulation of KIF18A at spindle poles, disrupting chromosome alignment and inducing mitotic arrest and apoptosis in CINHigh tumor cells (e.g., ovarian cancer OVCAR-3, breast cancer JIMT-1). VLS-1272 is a promising candidate for anti-tumor research[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: KIF18A-IN-7. CAS No. 2914878-00-3. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-153066. | |
| VLX1570 | VLX1570 is a competitive inhibitor of proteasome deubiquitinases (DUBs) with an IC50 of approximate 10 μM. Uses: Scientific research. Category: Signaling pathways. CAS No. 1431280-51-1. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-12471. | |
| VLX600 | VLX600 is an iron-chelating inhibitor of oxidative phosphorylation (OXPHOS). VLX600 causes mitochondrial dysfunction and induces a strong shift to glycolysis. VLX600 displays selective cytotoxic activity against malignant cell and induces autophagy. Anticancer activity[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 327031-55-0. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 250 mg. Product ID: HY-12406. | |
| VM&P Naptha | VM & P Naptha. Category ALIPHATIC SOLVENTS. Pack Sizes Bulk/ Drums |  |
| VNbAlC (MAX) Phase Ceramic Materials | VNbAlC (MAX) Phase Ceramic Materials. Purity: >90%. | |
| Vne I | One unit of the enzyme is the amount required to hydrolyze 1 μg of Lambda DNA in 1 hour at 37°C in a total reaction volume of 50 μl. Applications: After 10-fold overdigestion with enzyme 90% of the dna fragments can be ligated and recut. Group: Restriction Enzymes. Purity: 1000U; 5000U. G↑TGCAC CACGT↓G. Activity: 10000-20000u.a./ml. Appearance: 10 X SE-buffer O. Storage: -20°C. Form: Liquid. Source: An E.coli strain, that carries the cloned gene VneI from Vibrio nereis 18. Pack: 10 mM Tris-HCl (pH 7.5); 50 mM NaCl; 0,1 mM EDTA; 1 mM DTT; 200 μg/ml BSA; 50% glycerol. Cat No: ET-1186RE. | |
| VNPB | VNPB. Alternative Names: N4,N4'-di(Naphthalen-1-yl)-N4,N4'-bis(4- vinylphenyl)biphenyl-4,4'-diamine. CAS No. 1010396-31-2. Molecular formula: C48H36N2. Mole weight: 640.81. IUPAC Name: N-[4-[4-(4-ethenyl-N-naphthalen-1-ylanilino)phenyl]phenyl]-N-(4-ethenylphenyl)naphthalen-1-amine. SMILES: C=CC(C=C1)=CC=C1N(C2=CC=CC3=C2C=CC=C3)C(C=C4)=CC=C4C5=CC=C(N(C6=CC=C(C=C)C=C6)C7=CC=CC8=C7C=CC=C8)C=C5. InChI: 1S/C48H36N2/c1-3-35-19-27-41(28-20-35)49(47-17-9-13-39-11-5-7-15-45(39)47)43-31-23-37(24-32-43)38-25-33-44(34-26-38)50(42-29-21-36(4-2)22-30-42)48-18-10-14-40-12-6-8-16-46(40)48/h3-34H,1-2H2,WTEWXIOJLNVYBZ-UHFFFAOYSA-N. | |
| VNPP433-3β | VNPP433-3β (Galeterone 3β-imidazole) is an orally active molecular glue degrader, which degrades androgen receptor (AR) and its splice variants (AR-Vs) and MAP kinase-interacting serine/threonine protein kinase Mnk1/2. VNPP433-3β induces cell apoptosis. VNPP433-3β inhibits tumor growth in the CWR22Rv1 xenograft mouse model. VNPP433-3β can be used for the study of castration resistant prostate cancer (CRPC) and pancreatic ductal adenocarcinoma (PDAC)[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Galeterone 3β-imidazole. CAS No. 1630820-51-7. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-160777. | |
| VNT-101 | VNT-101 is an orally active influenza A (IAV) inhibitor. VNT-101 disrupts NP-NP PPI to block NP oligomerization and destabilize the viral ribonucleoprotein (RNP) complex, with potent antiviral activity across multiple influenza A subtypes. VNT-101 exhibits EC50 values of 4-5 nM in cellular cytopathic effect (CPE) assay, 4-8 nM in neuraminidase (NA) assay, and 21-45 nM in RNP assay. VNT-101 demonstrates robust in vivo antiviral efficacy in mice infected with lethal H1N1 virus. VNT-101 can be used for the study of influenza A infection[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2894060-67-2. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg. Product ID: HY-175469. | |
| Voacamine | Botanical Source: Group: Biochemicals. Alternative Names: Voacanginine. Grades: Plant Grade. CAS No. 3371-85-5. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Vobarilizumab | Vobarilizumab (ALX-0061) is a humanized bispecific anti-IL-6R and anti-human serum albumin (ALB) monoclonal antibody (mAb) (Kd: 0.19 pM). Vobarilizumab consists of an anti-IL-6R domain and an anti-human serum albumin domain. Vobarilizumab can be used in the research of inflammatory autoimmune diseases, such as rheumatoid arthritis[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: ALX-0061. CAS No. 1628814-88-9. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99385. | |
| Vobramitamab | Vobramitamab is a humanized B7-H3 monoclonal antibody (mAb). Vobramitamab conjugated with prodrug seco-DUBA (HY-132180A) via a cleavable linker, to form antibody-drug conjugate (ADC), the MGC018. MGC018 displays potent antitumor activity in preclinical tumor models of breast, ovarian, and lung cancer, as well as melanoma[1][2][3][4]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: AEX-4089; MGC026 antibody. CAS No. 2490556-50-6. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99101. | |
| Vociprotafib | Vociprotafib (RMC-4630) is an orally active, selective and potent phosphatase SHP2 inhibitor, which blocks activation of the RAS-RAF-MEK-ERK signaling pathway with antitumor activity. Vociprotafib accelerates the time to, and increases the magnitude of, tumor regressions in Osimertinib (HY-15772)-sensitive EGFR-mutant tumors of mice[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: RMC-4630; SHP2-IN-7. CAS No. 2172652-48-9. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-141523. | |
| Voclosporin | Voclosporin (ISAtx-247) is a calcineurin (PP2B) (CN) inhibitor[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: ISAtx-247. CAS No. 515814-01-4. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-106638. | |
| Voclosporin | Voclosporin, a structurally similar analogue of cyclosporin A, is a new type of calcineurin inhibitor. Category: Active pharmaceutical ingredients. Grades: USDMF. CAS No. 515814-01-4. Product ID: API515814014. Molecular formula: C63H111N11O12. Mole weight: 1214.65. Standard: GMP. |  |
| Vofatamab | Vofatamab (B-701) is an anti-FGFR3 monoclonal antibody (mAb). Vofatamab blocks activation of both the wildtype and genetically activated receptor. Vofatamab can be used in the research of metastatic urothelial carcinoma (mUC). Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001)[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: B-701; MFGR-1877S; RG-7444. CAS No. 1312305-12-6. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-P99384. | |
| Vofopitant dihydrochloride | Vofopitant dihydrochloride (GR 205171A) is a blood-brain barrier-permeable NK1 receptor inhibitor with a pKi of 9.02 in mice. Vofopitant dihydrochloride blocks vomiting-related responses and inhibits pseudoptyalism. Vofopitant dihydrochloride exerts anxiolytic effects, regulates 5-HT receptor function and increases central 5-HT release. Vofopitant dihydrochloride improves hyperarousal symptoms of post-traumatic stress disorder. Vofopitant dihydrochloride can be used in research related to depression, anxiety, vomiting and postoperative nausea and vomiting[1][2][3][4][5][6]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: GR 205171A. CAS No. 168266-51-1. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-12143. | |
| Vofopitant dihydrochloride | Vofopitant dihydrochloride. Alternative Names: 3-Piperidinamine, N-[[2-methoxy-5-[5-(trifluoro-methyl)-1H-tetrazol-1-yl]phenyl]methyl]-2-phenyl-, dihydrochloride, (2S,3S)-;3-Piperidinamine, N-[[2-methoxy-5-[5-(trifluoromethyl)-1H-tetrazol-1-yl]phenyl]methyl]-2-phenyl-, dihydrochloride, (2S-cis)-;GR 2. CAS No. 168266-51-1. Product ID: ACM168266511. Molecular formula: C21H23F3N6O2HCl. Alfa Chemistry - ISO 9001:32057 Certified. |  |
| Voglibose | Voglibose is an orally active alpha-glucosidase inhibitor that prevents the development of colorectal precancerous lesions induced by obesity and diabetes. Voglibose reduces oxidative stress in an inflammatory environment and inhibits the insulin-like growth factor/insulin-like growth factor-1 receptor (IGF/IGF-1R) functional axis[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 83480-29-9. Pack Sizes: 10 mM * 1 mL in DMSO; 50 mg; 100 mg. Product ID: HY-B0025. | |
| Voglibose | Voglibose. Group: Biochemicals. Grades: Purified. CAS No. 83480-29-9. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| Voglibose | Voglibose is an alpha-glucosidase inhibitor that is taken orally to improve diabetic postprandial hyperglycemia. Category: Active pharmaceutical ingredients. CAS No. 83480-29-9. Product ID: API83480299. Molecular formula: C10H21NO7. Mole weight: 267.28. Standard: JP/CP. | |
| Voglibose Impurity 1 | Voglibose Impurity 1. Uses: For analytical and research use. CAS No. 6564-72-3. Molecular formula: C34H36O6. Mole weight: 540.66. Catalog: APB6564723. |  |
| Voglibose Impurity 10 | Voglibose Impurity 10. Uses: For analytical and research use. CAS No. 911439-19-5. Molecular formula: C35H36O6. Mole weight: 552.67. Catalog: APB911439195. | |
| Voglibose Impurity 11 | Voglibose Impurity 11. Uses: For analytical and research use. CAS No. 306968-48-9. Molecular formula: C35H36O6. Mole weight: 552.67. Catalog: APB306968489. | |
| Voglibose Impurity 12 | Voglibose Impurity 12. Uses: For analytical and research use. Molecular formula: C22H41NO17. Mole weight: 591.56. Catalog: APB11412. | |
| Voglibose Impurity 13 | Voglibose Impurity 13. Uses: For analytical and research use. Molecular formula: C22H41NO17. Mole weight: 591.56. Catalog: APB11413. | |
| Voglibose Impurity 14 | Voglibose Impurity 14. Uses: For analytical and research use. Molecular formula: C22H41NO17. Mole weight: 591.56. Catalog: APB11414. | |
| Voglibose Impurity 16 | Voglibose Impurity 16. Uses: For analytical and research use. Molecular formula: C10H21NO7. Mole weight: 267.28. Catalog: APB11415. | |
| Voglibose Impurity 17 | Voglibose Impurity 17. Uses: For analytical and research use. Molecular formula: C10H21NO8. Mole weight: 283.28. Catalog: APB11416. | |
| Voglibose Impurity 18 | Voglibose Impurity 18. Uses: For analytical and research use. Molecular formula: C16H31NO12. Mole weight: 429.42. Catalog: APB11417. | |
| Voglibose Impurity 19 | Voglibose Impurity 19. Uses: For analytical and research use. Molecular formula: C22H41NO17. Mole weight: 591.56. Catalog: APB11418. | |
| Voglibose Impurity 2 | Voglibose Impurity 2. Uses: For analytical and research use. CAS No. 1303996-67-9. Molecular formula: C17H34N2O11. Mole weight: 442.26. Catalog: APB1303996679. | |
| Voglibose Impurity 20 | Voglibose Impurity 20. Uses: For analytical and research use. Molecular formula: C22H41NO17. Mole weight: 591.56. Catalog: APB11419. | |
| Voglibose Impurity 3 | Voglibose Impurity 3. Uses: For analytical and research use. CAS No. 1303996-66-8. Molecular formula: C17H34N2O11. Mole weight: 442.26. Catalog: APB1303996668. | |
| Voglibose Impurity 4 | Voglibose Impurity 4. Uses: For analytical and research use. CAS No. 4132-28-9. Molecular formula: C34H36O6. Mole weight: 540.66. Catalog: APB4132289. | |
| Voglibose Impurity 5 | Voglibose Impurity 5. Uses: For analytical and research use. CAS No. 115250-39-0. Molecular formula: C38H45NO7. Mole weight: 627.32. Catalog: APB115250390. | |
| Voglibose Impurity 6 | Voglibose Impurity 6. Uses: For analytical and research use. CAS No. 83465-22-9. Molecular formula: C7H15NO5. Mole weight: 193.2. Catalog: APB83465229. | |
| Voglibose Impurity 7 | Voglibose Impurity 7. Uses: For analytical and research use. Molecular formula: C10H21NO7. Mole weight: 267.28. Catalog: APB11409. | |
| Voglibose Impurity 8 | Voglibose Impurity 8. Uses: For analytical and research use. Molecular formula: C10H21NO7. Mole weight: 267.28. Catalog: APB11411. | |
| Voglibose Impurity 9 | Voglibose Impurity 9. Uses: For analytical and research use. Molecular formula: C10H21NO7. Mole weight: 267.28. Catalog: APB11410. | |
Our database is helping our users find suppliers everyday.
